| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-13 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.21 | 8e-11 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-07 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-05 |